Diabetes is a disease associated with significant, life threatening complications. Adequate glycemic control is essential to prevent micro- and macrovascular complications. Despite the wide dissemination of published evidence and clinical guidelines, fewer than half of individuals with diabetes achieve glycemic control. Providers contribute to this problem by not initiating or intensifying therapy when warranted. Clinical inertia, which is recognizing a clinical problem but failing to act on it, is a significant contributor to uncontrolled hyperglycemia in the care of patients with type 2 diabetes (T2DM). Causes of clinical inertia include lack of knowledge or experience with insulin management and poor appreciation for the progressive natu...
Background: Clinical inertia is related to the difficulty of achieving and maintaining optimal glyce...
Introduction: Evidence has demonstrated clinical or prescriptive inertia along with an increased pre...
The diabetes epidemic in the US affects over 29 million individuals every day. Type 2 diabetes accou...
Diabetes is a disease associated with significant, life threatening complications. Adequate glycemic...
Many people with type 2 diabetes mellitus (T2DM) fail to achieve glycaemic control promptly after di...
Clinical inertia and poor knowledge by many physicians play an important role in delaying diabetes c...
AIM: To investigate whether clinical inertia, the failure to intensify treatment regimens when requi...
Early glycaemic control leads to better outcomes, including a reduction in long-term macrovascular a...
Early glycaemic control leads to better outcomes, including a reduction in long-term macrovascular a...
Early glycaemic control leads to better outcomes, including a reduction in long-term macrovascular a...
This review seeks to establish, through the recent available literature, the prevalence of therapeut...
Early glycaemic control leads to better outcomes, including a reduction in long-term macrovascular a...
Early glycaemic control leads to better outcomes, including a reduction in long-term macrovascular a...
Early glycaemic control leads to better outcomes, including a reduction in long-term macrovascular a...
Early glycaemic control leads to better outcomes, including a reduction in long-term macrovascular a...
Background: Clinical inertia is related to the difficulty of achieving and maintaining optimal glyce...
Introduction: Evidence has demonstrated clinical or prescriptive inertia along with an increased pre...
The diabetes epidemic in the US affects over 29 million individuals every day. Type 2 diabetes accou...
Diabetes is a disease associated with significant, life threatening complications. Adequate glycemic...
Many people with type 2 diabetes mellitus (T2DM) fail to achieve glycaemic control promptly after di...
Clinical inertia and poor knowledge by many physicians play an important role in delaying diabetes c...
AIM: To investigate whether clinical inertia, the failure to intensify treatment regimens when requi...
Early glycaemic control leads to better outcomes, including a reduction in long-term macrovascular a...
Early glycaemic control leads to better outcomes, including a reduction in long-term macrovascular a...
Early glycaemic control leads to better outcomes, including a reduction in long-term macrovascular a...
This review seeks to establish, through the recent available literature, the prevalence of therapeut...
Early glycaemic control leads to better outcomes, including a reduction in long-term macrovascular a...
Early glycaemic control leads to better outcomes, including a reduction in long-term macrovascular a...
Early glycaemic control leads to better outcomes, including a reduction in long-term macrovascular a...
Early glycaemic control leads to better outcomes, including a reduction in long-term macrovascular a...
Background: Clinical inertia is related to the difficulty of achieving and maintaining optimal glyce...
Introduction: Evidence has demonstrated clinical or prescriptive inertia along with an increased pre...
The diabetes epidemic in the US affects over 29 million individuals every day. Type 2 diabetes accou...